Hemolytic-Uremic Syndrome clinical trials

The registry lists 28 studies for Hemolytic-Uremic Syndrome across more than 10 countries. 7 are recruiting or about to start. 16 of them are mainly about Hemolytic-Uremic Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its narrower condition Atypical Hemolytic Uremic Syndrome too: 70 studies, 19 open.

Get an email when these change. Save the Hemolytic-Uremic Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 11
Recruiting: 6
Terminated: 4
Status unknown: 3
Withdrawn: 2
Not yet recruiting: 1

Phase

Phase 3: 6
Phase 2: 3
Phase 1: 1
Phase 4: 1

Where

France: 7
United States: 7
Canada: 5
Argentina: 4
Germany: 2
Italy: 2

Who runs them

Inmunova S.A. (3) · University Hospital, Tours (2) · Assiut University (2) · University of Calgary (2) · University Children's Hospital, Zurich (1) · Universitätsklinikum Hamburg-Eppendorf (1) · University of Alabama at Birmingham (1) · Fundación Grupo de Investigación en Cuidados Intensivos y Obstetricia (1)

What is being tested here

Drugs under test in Hemolytic-Uremic Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
INM004	1	2	3
Eculizumab	0	1	1
Erythropoietin	0	0	1
Rituximab	0	0	1

Coming up

1phase 3 study under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Dec 2026Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium · Maastricht University Medical Center
Aug 2027Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection · University of Calgary

Who these studies take

Of the 6 Hemolytic-Uremic Syndrome studies recruiting now, 4 (67%) set no upper age limit and 2 (33%) stop at 75 or younger. 2 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (17%) take healthy volunteers.

Recruiting studies that take each age, of 6
Age	Women	Men
10	2 (33%)	2 (33%)
18	5 (83%)	5 (83%)
30	4 (67%)	4 (67%)
40	4 (67%)	4 (67%)
50	4 (67%)	4 (67%)
65	4 (67%)	4 (67%)
75	4 (67%)	4 (67%)
85	4 (67%)	4 (67%)

Across all 28 studies, recruiting or not: 50% stop at 75 or younger and 50% at 65; 75% take children; 4% are for women only and 0% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 28 of 28. search them.